Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Fortress Biotech, Inc. | fbio-20201231xex32d2.htm |
| EX-32.1 - EX-32.1 - Fortress Biotech, Inc. | fbio-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Fortress Biotech, Inc. | fbio-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Fortress Biotech, Inc. | fbio-20201231xex31d1.htm |
| EX-21.1 - EX-21.1 - Fortress Biotech, Inc. | fbio-20201231xex21d1.htm |
| EX-4.3 - EX-4.3 - Fortress Biotech, Inc. | fbio-20201231xex4d3.htm |
| 10-K - 10-K - Fortress Biotech, Inc. | fbio-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Fortress Biotech, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-238327) and Form S-8 (Nos. 333-184616, 333-194588, 333-20664, 333-221458, 333-233195 and 333-249985) of Fortress Biotech, Inc. of our report dated March 31, 2021 relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP |
| |
| | |
Boston, Massachusetts | | |
March 31, 2021 | | |